Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Multifocal myoclonus induced by haloperidol.

Domínguez C, Benito-León J, Bermejo-Pareja F.

Neurol Sci. 2009 Oct;30(5):385-6. doi: 10.1007/s10072-009-0104-0. Epub 2009 Jun 13.

PMID:
19526195
2.

Pilot study of haloperidol, fluoxetine, and placebo for agitation in Alzheimer's disease.

Auchus AP, Bissey-Black C.

J Neuropsychiatry Clin Neurosci. 1997 Fall;9(4):591-3.

PMID:
9447502
3.

Treatment of Alzheimer's disease.

De Deyn PP.

N Engl J Med. 2000 Mar 16;342(11):821; author reply 821-2. No abstract available.

4.

Olanzapine versus haloperidol in the treatment of agitation in elderly patients with dementia: results of a randomized controlled double-blind trial.

Verhey FR, Verkaaik M, Lousberg R; Olanzapine-Haloperidol in Dementia Study group.

Dement Geriatr Cogn Disord. 2006;21(1):1-8. Epub 2005 Oct 21.

PMID:
16244481
5.

Neuroleptic drugs in the management of behavioral symptoms of Alzheimer's disease.

Tune LE, Steele C, Cooper T.

Psychiatr Clin North Am. 1991 Jun;14(2):353-73.

PMID:
1676507
6.

Olanzapine-induced myoclonic status.

Camacho A, García-Navarro M, Martínez B, Villarejo A, Pomares E.

Clin Neuropharmacol. 2005 May-Jun;28(3):145-7.

PMID:
15965316
7.

A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease.

Devanand DP, Pelton GH, Cunqueiro K, Sackeim HA, Marder K.

Int J Geriatr Psychiatry. 2011 Sep;26(9):937-43. doi: 10.1002/gps.2630. Epub 2010 Dec 28.

8.
9.

A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances.

Suh GH, Son HG, Ju YS, Jcho KH, Yeon BK, Shin YM, Kee BS, Choi SK.

Am J Geriatr Psychiatry. 2004 Sep-Oct;12(5):509-16.

PMID:
15353389
10.

Olanzapine-associated myoclonus.

Rosen JB, Milstein MJ, Haut SR.

Epilepsy Res. 2012 Feb;98(2-3):247-50. doi: 10.1016/j.eplepsyres.2011.07.020. Epub 2011 Dec 21.

PMID:
22196307
11.

Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effects.

Lane HY, Chang YC, Su MH, Chiu CC, Huang MC, Chang WH.

J Clin Psychopharmacol. 2002 Feb;22(1):4-10.

PMID:
11799336
12.

Behavioral symptoms in dementia: community-based research.

Auer SR, Monteiro IM, Reisberg B.

Int Psychogeriatr. 1996;8 Suppl 3:363-6; discussion 381-2. No abstract available.

PMID:
9154589
13.

Possible toxic encephalopathy following high-dose intravenous haloperidol.

Maxa JL, Taleghani AM, Ogu CC, Tanzi M.

Ann Pharmacother. 1997 Jun;31(6):736-7.

PMID:
9184715
14.

Does behavioral improvement with haloperidol or trazodone treatment depend on psychosis or mood symptoms in patients with dementia?

Sultzer DL, Gray KF, Gunay I, Wheatley MV, Mahler ME.

J Am Geriatr Soc. 2001 Oct;49(10):1294-300.

PMID:
11890487
15.

Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol.

McSwain ML, Forman LM.

J Clin Psychopharmacol. 1995 Aug;15(4):284. No abstract available.

PMID:
7593712
16.

Reversible anorexia and rapid weight loss associated with neuroleptic administration in Alzheimer's disease.

Rohrbaugh RM, Siegal AP.

J Geriatr Psychiatry Neurol. 1989 Jan-Mar;2(1):45-7.

PMID:
2568117
17.

Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone.

Meibach RC.

Neurology. 2000 Oct 10;55(7):1069. No abstract available.

PMID:
11061283
18.

Neuroleptic malignant syndrome and cardiac surgery. A case report.

Sirois F.

J Cardiovasc Surg (Torino). 2008 Oct;49(5):695-6.

PMID:
18670390
19.

The use of haloperidol in the agitated, critically ill pediatric patient with burns.

Brown RL, Henke A, Greenhalgh DG, Warden GD.

J Burn Care Rehabil. 1996 Jan-Feb;17(1):34-8.

PMID:
8808357
20.

Managing severe aggression in frontotemporal dementia.

Powell A, Flynn P, Rischbieth S, McKellar D.

Australas Psychiatry. 2014 Feb;22(1):86-9. doi: 10.1177/1039856213510576. Epub 2013 Oct 31.

PMID:
24176944

Supplemental Content

Support Center